CYTK
Price
$36.59
Change
-$0.03 (-0.08%)
Updated
Jul 10 closing price
Capitalization
4.37B
20 days until earnings call
IKT
Price
$2.00
Change
-$0.02 (-0.99%)
Updated
Jul 10 closing price
Capitalization
150.17M
Interact to see
Advertisement

CYTK vs IKT

Header iconCYTK vs IKT Comparison
Open Charts CYTK vs IKTBanner chart's image
Cytokinetics
Price$36.59
Change-$0.03 (-0.08%)
Volume$1.16M
Capitalization4.37B
Inhibikase Therapeutics
Price$2.00
Change-$0.02 (-0.99%)
Volume$75.87K
Capitalization150.17M
CYTK vs IKT Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. IKT commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and IKT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (CYTK: $36.59 vs. IKT: $2.00)
Brand notoriety: CYTK and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 70% vs. IKT: 25%
Market capitalization -- CYTK: $4.37B vs. IKT: $150.17M
CYTK [@Biotechnology] is valued at $4.37B. IKT’s [@Biotechnology] market capitalization is $150.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CYTK and IKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while IKT’s TA Score has 6 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 3 bearish.
  • IKT’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IKT is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а +5.57% price change this week, while IKT (@Biotechnology) price change was +5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

IKT is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.37B) has a higher market cap than IKT($150M). CYTK YTD gains are higher at: -22.215 vs. IKT (-38.462). IKT has higher annual earnings (EBITDA): -39.54M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. IKT (93.2M). IKT has less debt than CYTK: IKT (74.8K) vs CYTK (791M). CYTK has higher revenues than IKT: CYTK (19.2M) vs IKT (0).
CYTKIKTCYTK / IKT
Capitalization4.37B150M2,916%
EBITDA-513.62M-39.54M1,299%
Gain YTD-22.215-38.46258%
P/E RatioN/AN/A-
Revenue19.2M0-
Total Cash938M93.2M1,006%
Total Debt791M74.8K1,057,487%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIKT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGGNF3.580.16
+4.83%
Legal & General Group Plc
CIBH34.040.29
+0.86%
CIB Marine Bancshares, Inc.
BYDGF155.60N/A
N/A
BOYD GROUP SVCS INC.
AMNCB0.03N/A
N/A
Amincor Inc
AUCTF8.96N/A
N/A
Aucnet Inc

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-0.99%
CRGX - IKT
44%
Loosely correlated
N/A
ARWR - IKT
34%
Loosely correlated
-0.11%
IDYA - IKT
34%
Loosely correlated
-0.74%
SYRE - IKT
33%
Loosely correlated
-3.56%
CGON - IKT
32%
Poorly correlated
+0.26%
More